Accretion Pharmaceuticals Ltd.
ACCPL
Accretion Pharmaceuticals Ltd. Share Price
143.45 -7.55 (-5.00%)Fundamentals
Market Cap₹160Cr | EPS₹9.02 |
Book Value/Share₹14.87 | P/E Ratio (TTM)16.49 |
Industry P/E (TTM)40.84 | P/B Ratio10.48 |
Long Term D/E0.22 | ROE27.62% |
Dividend Yield (TTM)0.00% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Strong Outperformer
Good Quality
High Price Fluctuation
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Accretion Pharmaceuticals Ltd.
What is the share price of Accretion Pharmaceuticals Ltd.?
The share price of Accretion Pharmaceuticals Ltd. is ₹143.45 on NSE as of 21/6/2026, 8:10:08 am. Share prices may change frequently due to market movements.
What is the market capitalisation of Accretion Pharmaceuticals Ltd.?
The market capitalisation of Accretion Pharmaceuticals Ltd. is ₹160Cr as of 21/6/2026, 8:10:08 am
What is the current P/E ratio of Accretion Pharmaceuticals Ltd.?
The current Price to Earnings (P/E) ratio of Accretion Pharmaceuticals Ltd. is 16.50 as of 21/6/2026, 8:10:08 am
What is the current P/B ratio of Accretion Pharmaceuticals Ltd.?
The Price to Book (P/B) ratio of Accretion Pharmaceuticals Ltd. stands at 10.48 as of 21/6/2026, 8:10:08 am
What is the ROE of Accretion Pharmaceuticals Ltd.?
Accretion Pharmaceuticals Ltd. reported an ROE of 27.62% for the last reported financial year on a consolidated account basis.
What is the shareholding pattern of Accretion Pharmaceuticals Ltd.?
As of 21/6/2026, 8:10:08 am, Accretion Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 73.50%, FIIs hold 0.00%, DIIs hold 0.00%, and public shareholders hold 26.50%.
What is the 52-week high and low of Accretion Pharmaceuticals Ltd.?
The 52-week high of Accretion Pharmaceuticals Ltd. is ₹151.00 and the 52-week low is ₹143.45 as of 21/6/2026, 8:10:08 am.
What is the EPS of Accretion Pharmaceuticals Ltd.?
The earnings per share (EPS) of Accretion Pharmaceuticals Ltd. is ₹3.39 for the quarter ended Dec 2024.
What is the stock symbol of Accretion Pharmaceuticals Ltd.?
The stock symbol of Accretion Pharmaceuticals Ltd. is ACCPL.
How to buy Accretion Pharmaceuticals Ltd.?
You can buy Accretion Pharmaceuticals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
What is the fair value of Accretion Pharmaceuticals Ltd.?
The fair value of Accretion Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Dec 2024 | Q/Q Change |
|---|---|---|
| Operating Revenue | 17.10 | - |
| Other Income | 0.07 | - |
| Total Income | 17.17 | - |
| Total Expenditure | 12.70 | - |
| EBIDT | 4.47 | - |
| Depreciation | 0.21 | - |
| Interest | 0.37 | - |
| Tax | 1.12 | - |
| Net Profit | 2.77 | - |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 60.59 |
| Total Non-Current Assets | 16.06 |
| Fixed assets | 13.41 |
| Total Assets | 76.66 |
| Total Current liabilities | 20.81 |
| Total Non Current Liabilities | 1.13 |
| Total Equity Plus Liabilities | 76.66 |
| Total Shareholder Funds | 54.71 |
| Total Debt to Equity | 23.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | -14.62 |
| Cash from Financing Activities | 27.12 |
| Cash from Investing Activities | -8.53 |
| Net Cash Flow | 3.97 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages14
Bearish Moving Averages2
5 Day
145.7010 Day
141.4020 Day
134.6030 Day
129.1050 Day
114.40100 Day
91.10150 Day
88.00200 Day
81.00Indicators
RSI (14)
61.79MACD (12, 26)
9.28MACD Signal Line (9)
9.40MFI (14)
74.71ATR (14)
7.03ADX (14)
35.64ROC (21)
26.95ROC (125)
47.58Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 148.48 | 153.52 | 156.03 | 145.97 | 140.93 | 138.42 | 133.38 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Accretion Pharmaceuticals Ltd.
ACCPL
Open Price | 151.00 |
Prev Close | 151.00 |
Upper Circuit | 150.60 |
Lower Circuit | 136.30 |
Volume | 18,000 |
Average Traded Price | 144.51 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |